Podcasts · Research To Practice | Oncology Videos

Chronic Lymphocytic Leukemia — Microlearning Activity 1

· 25 min

Episode Chronic Lymphocytic Leukemia — Microlearning Activity 1

0:00 24:33

Featuring perspectives from Dr Catherine C Coombs, including the following topics:

• Early versus delayed addition of obinutuzumab to acalabrutinib and venetoclax in treatment-naïve chronic lymphocytic leukemia (CLL) (0:00) • Feasibility of discontinuation of Bruton tyrosine kinase (BTK) inhibitor therapy in CLL; minimal residual disease and disease monitoring (4:10) • Ongoing Phase III trials of BTK inhibitor/B-cell lymphoma 2 inhibitor combinations in previously untreated CLL (10:05) • Pirtobrutinib as first-line therapy for CLL and long-term safety data (15:22)

CME information and select publications

Links in the notes 1

The episode on the publisher’s site

Shows are listed from Apple Podcasts' charts and directory, and Podcast Index where it is used. Every show and episode belongs to its publisher and plays from the publisher's own feed; this site hosts none of them. Explicit shows are for adult profiles only, and children’s profiles hear only children’s shows. More about this list.